We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

82 hedge funds and large institutions have $272M invested in Albireo Pharma Inc in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

295% more call options, than puts

Call options by funds: $4.75M | Put options by funds: $1.2M

79% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 19

57% more capital invested

Capital invested by funds: $173M → $272M (+$98.7M)

19% more funds holding

Funds holding: 69 → 82 (+13)

Holders
82
Holders Change
+13
Holders Change %
+18.84%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
19
Closed
4
Calls
$4.75M
Puts
$1.2M
Net Calls
+$3.54M
Net Calls Change
+$930K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.32M
2
Marshall Wace
Marshall Wace
United Kingdom
+$2M
3
Deutsche Bank
Deutsche Bank
Germany
+$1.4M
4
SCM
Suvretta Capital Management
New York
+$752K
5
DCM
Driehaus Capital Management
Illinois
+$708K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.02M
2
Victory Capital Management
Victory Capital Management
Texas
-$5.9M
3
PM
Prosight Management
Texas
-$3.1M
4
AG
Artal Group
Luxembourg
-$2.07M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$949K
Name Holding Trade Value Shares
Change 		Change in
Stake
William Blair & Company
26
William Blair & Company
Illinois
$976K -$84.5K -3,582 -9%
Two Sigma Investments
27
Two Sigma Investments
New York
$953K +$100K +4,251 +13%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$948K +$57.4K +2,434 +7%
Charles Schwab
29
Charles Schwab
California
$910K +$37.2K +1,576 +5%
Wells Fargo
30
Wells Fargo
California
$857K +$560K +23,755 +277%
PPA
31
Parametric Portfolio Associates
Washington
$813K +$75.1K +3,183 +12%
DCM
32
Driehaus Capital Management
Illinois
$795K +$708K +30,000 New
Prudential Financial
33
Prudential Financial
New Jersey
$727K -$69.4K -2,941 -10%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$713K +$220K +9,345 +53%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$649K +$578K +24,517 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$572K +$109K +4,600 +27%
AA
37
ALPS Advisors
Colorado
$541K -$144K -6,095 -23%
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$538K +$84.9K +3,600 +22%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$514K – – –
Goldman Sachs
40
Goldman Sachs
New York
$497K +$128K +5,413 +41%
Citadel Advisors
41
Citadel Advisors
Florida
$474K +$168K +7,105 +66%
Man Group
42
Man Group
United Kingdom
$462K +$411K +17,438 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$457K +$81.3K +3,445 +25%
MCM
44
MAI Capital Management
Ohio
$442K +$120K +5,100 +44%
AllianceBernstein
45
AllianceBernstein
Tennessee
$408K +$96.7K +4,100 +36%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$360K +$80.2K +3,400 +33%
Los Angeles Capital Management
47
Los Angeles Capital Management
California
$347K +$309K +13,110 New
PC
48
PA Capital
Virginia
$344K -$241K -10,211 -44%
Acadian Asset Management
49
Acadian Asset Management
Massachusetts
$313K -$77.4K -3,281 -22%
M&T Bank
50
M&T Bank
New York
$261K +$233K +9,869 New
1
2
3 4

ALBO Hedge Fund Activity: Q2 2020 in Review

82 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2020, worth a combined $272M — up 57% from $173M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ALBO positions and 4 closed out — a net gain of 13 holders — while 34 added to existing stakes and 19 trimmed.

The largest buyer was BlackRock, adding an estimated $3.32M. The largest seller was Point72 Asset Management, cutting an estimated $8.02M.

  • 82 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2020, up from 69 in Q1 2020.
  • Funds reported $272M of Albireo Pharma Inc stock for Q2 2020, up 57% quarter-over-quarter.
  • 17 funds opened new Albireo Pharma Inc positions in Q2 2020 and 4 closed out, a net change of +13 holders.
  • The largest Albireo Pharma Inc buyer in Q2 2020 was BlackRock, an estimated $3.32M added.
  • The largest Albireo Pharma Inc seller in Q2 2020 was Point72 Asset Management, an estimated $8.02M sold.

Based on aggregated 13F filings for Q2 2020.